SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-042369
Filing Date
2024-05-13
Accepted
2024-05-13 16:45:43
Documents
13
Period of Report
2024-05-08
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0205933-8k_oncone.htm   iXBRL 8-K 27009
  Complete submission text file 0001213900-24-042369.txt   203205

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE onco-20240508.xsd EX-101.SCH 3042
3 XBRL LABEL FILE onco-20240508_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE onco-20240508_pre.xml EX-101.PRE 22377
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0205933-8k_oncone_htm.xml XML 3795
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Filer) CIK: 0001782107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41294 | Film No.: 24939835
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)